Learn More
Medchemexpress LLC Navlimetostat hydrochloride | 00-00-0 | 99.2% | C23H19Cl2FN6O2 | 10MG

Supplier: Medchemexpress LLC HY139611C10MG
Navlimetostat hydrochloride is a research-grade small-molecule inhibitor selective for the PRMT5-MTA complex. It demonstrates potent biochemical and cellular activity and is used in preclinical studies to probe PRMT5 biology and evaluate antineoplastic effects, with reported selectivity in MTAP-deleted models.
- Potent inhibitor of the PRMT5-MTA complex (IC50 3.6 nM).
- Inhibits PRMT5 enzymatic activity (IC50 20.5 nM).
- Shows cellular selectivity in MTAP-deleted models (cell viability 12 nM vs 890 nM in parental cells).
- High purity (99.2%).
- Soluble in DMSO at 100 mg/mL; ultrasonic assistance recommended.
- Suitable for preclinical research; store sealed away from moisture.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.